Last Updated: September 28, 2026

ZINC CHLORIDE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Zinc Chloride, and what generic alternatives are available?

Zinc Chloride is a drug marketed by Exela Pharma, Somerset, Stira, and Hospira. and is included in four NDAs.

The generic ingredient in ZINC CHLORIDE is zinc chloride. Three suppliers are listed for this compound. Additional details are available on the zinc chloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zinc Chloride

A generic version of ZINC CHLORIDE was approved as zinc chloride by EXELA PHARMA on May 21^st, 2021.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ZINC CHLORIDE?
What are the global sales for ZINC CHLORIDE?
What is Average Wholesale Price for ZINC CHLORIDE?

Summary for ZINC CHLORIDE

US Patents:	0
Applicants:	4
NDAs:	4

US Patents and Regulatory Information for ZINC CHLORIDE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Exela Pharma	ZINC CHLORIDE	zinc chloride	INJECTABLE;INJECTION	212007-001	May 21, 2021	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hospira	ZINC CHLORIDE IN PLASTIC CONTAINER	zinc chloride	INJECTABLE;INJECTION	018959-001	Jun 26, 1986	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Somerset	ZINC CHLORIDE	zinc chloride	INJECTABLE;INJECTION	216152-001	Oct 16, 2024	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Stira	ZINC CHLORIDE	zinc chloride	INJECTABLE;INJECTION	217625-001	Apr 14, 2025	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.